# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001367644-23-000112
Filing Date
2023-05-31
Accepted
2023-05-31 17:00:59
Documents
20
Period of Report
2023-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ebs-20230525.htm iXBRL | 8-K | 71833
2 | EX-99.1 | ebsvasm2023-slidesxfinal.htm | EX-99.1 | 12017
6 |  | ebsvasm2023-slidesxfinal001.jpg | GRAPHIC | 87684
7 |  | ebsvasm2023-slidesxfinal002.jpg | GRAPHIC | 116739
8 |  | ebsvasm2023-slidesxfinal003.jpg | GRAPHIC | 73681
9 |  | ebsvasm2023-slidesxfinal004.jpg | GRAPHIC | 88425
10 |  | ebsvasm2023-slidesxfinal005.jpg | GRAPHIC | 84029
11 |  | ebsvasm2023-slidesxfinal006.jpg | GRAPHIC | 211492
12 |  | ebsvasm2023-slidesxfinal007.jpg | GRAPHIC | 87684
| Complete submission text file | 0001367644-23-000112.txt |  | 1267009

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20230525.xsd | EX-101.SCH | 1965
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20230525_lab.xml | EX-101.LAB | 25154
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20230525_pre.xml | EX-101.PRE | 13100
14 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20230525_htm.xml | XML | 11453

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 23981859
SIC: 2834 Pharmaceutical Preparations